Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review. (2008)

First Author: Swart AM
Attributed to:  Systematic reviews and meta-analysis funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdm518

PubMed Identifier: 18006894

Publication URI: http://europepmc.org/abstract/MED/18006894

Type: Journal Article/Review

Volume: 19

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 4

ISSN: 0923-7534